Company Filing History:
1 out of 223 
1 out of 238 
Years Active: 2013
Title: Amantha Thathiah: Innovator in Alzheimer's Research
Introduction
Amantha Thathiah is a notable inventor based in Leuven, Belgium. She has made significant contributions to the field of neuroscience, particularly in the context of Alzheimer's disease. Her innovative work focuses on the modulation of GPR3-mediated beta-arrestin signaling, which is crucial for understanding and potentially treating neurodegenerative disorders.
Latest Patents
Amantha Thathiah holds a patent titled "Screening for compounds that modulate GPR3-mediated beta-arrestin signaling and amyloid beta peptide generation." This invention addresses disorders of the peripheral or central nervous system, with a specific emphasis on Alzheimer's disease. The patent outlines methods for screening compounds that can modulate GPR3 activity and beta-arrestin signaling in mammalian cells. It also discusses the development of inhibiting agents targeting beta-arrestin signaling and their pharmaceutical applications in treating these disorders.
Career Highlights
Throughout her career, Amantha has worked with esteemed organizations such as Vib Vzw and Katholieke Universiteit Leuven, also known as KU Leuven R&D. Her experience in these institutions has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Amantha Thathiah has collaborated with Bart De Strooper, a prominent figure in Alzheimer's research. Their partnership has fostered advancements in understanding the mechanisms underlying neurodegenerative diseases.
Conclusion
Amantha Thathiah's innovative work in Alzheimer's research exemplifies her commitment to advancing medical science. Her patent and collaborations highlight her significant contributions to the field, paving the way for future developments in the treatment of neurodegenerative disorders.